SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001113148-20-000016
Filing Date
2020-05-11
Accepted
2020-05-11 07:24:23
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q infi-20200331x10q.htm 10-Q 988129
2 EXHIBIT 31.1 ex-311q12020.htm EX-31.1 10551
3 EXHIBIT 31.2 ex-312q12020.htm EX-31.2 11798
4 EXHIBIT 32.1 ex-321q12020.htm EX-32.1 6179
5 EXHIBIT 32.2 ex-322q12020.htm EX-32.2 6220
  Complete submission text file 0001113148-20-000016.txt   4222654

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT infi-20200331.xml EX-101.INS 622216
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20200331.xsd EX-101.SCH 53709
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20200331_cal.xml EX-101.CAL 71127
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20200331_def.xml EX-101.DEF 197407
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20200331_lab.xml EX-101.LAB 527336
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20200331_pre.xml EX-101.PRE 293272
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 20862614
SIC: 2834 Pharmaceutical Preparations